Second-generation antipsychotics and the metabolic syndrome
- PMID: 15935125
- DOI: 10.1007/s11920-005-0044-1
Second-generation antipsychotics and the metabolic syndrome
Similar articles
-
[Comment about the article "Psychopharmaceuticals and diabetes" of Ress C, Tschoner A, Kaser S, and Ebenbichler CF in Wiener Medizinische Wochenschrift 2011; 161/21-22: 531-42].Wien Med Wochenschr. 2012 Dec;162(23-24):541-2; author reply 543. doi: 10.1007/s10354-012-0152-6. Epub 2012 Nov 8. Wien Med Wochenschr. 2012. PMID: 23135252 German. No abstract available.
-
Metabolic screening for patients with second-generation antipsychotic medication: A population-based study from 2004 to 2016.Schizophr Res. 2018 Jul;197:618-619. doi: 10.1016/j.schres.2018.02.028. Epub 2018 Feb 22. Schizophr Res. 2018. PMID: 29477247 No abstract available.
-
[Psychotropic drugs and diabetes].Wien Med Wochenschr. 2011 Nov;161(21-22):531-42. doi: 10.1007/s10354-011-0004-9. Epub 2011 Jul 29. Wien Med Wochenschr. 2011. PMID: 21792529 Review. German.
-
Serum metabolite profile associates with the development of metabolic co-morbidities in first-episode psychosis.Transl Psychiatry. 2016 Nov 15;6(11):e951. doi: 10.1038/tp.2016.222. Transl Psychiatry. 2016. PMID: 27845774 Free PMC article.
-
Screening for the metabolic syndrome in patients receiving antipsychotic treatment: a proposed algorithm.Med J Aust. 2009 Feb 16;190(4):185-9. doi: 10.5694/j.1326-5377.2009.tb02344.x. Med J Aust. 2009. PMID: 19220182 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical